RSV readiness in adult social care before 1 September 2026
A new resident arrives with medicines, mobility needs, family contact details and a care plan to review. From 1 September 2026, in England, RSV vaccination status should also be part of that conversation for older-adult care homes.
RSV is often associated with children, but it can cause serious lung infection in older adults, including breathing difficulty, hospital admission and risk to life. UKHSA estimates around 175,000 RSV-associated GP episodes each year in UK adults aged 65 and over, and 5,000 to 7,500 RSV-associated deaths each winter in older adults in England and Wales.
For care assistants, nurses, HCAs and managers, the practical task is not to make a clinical eligibility decision independently. It is to make sure the service has a reliable route for identifying possible eligibility, supporting informed decisions, coordinating with the responsible vaccination provider and keeping clear records.
Direct answer: From 1 September 2026, the NHS older-adult RSV programme in England will offer one dose to everyone aged 75 and over, adults living in or moving into a care home for older adults, and eligible people aged 65 to 74 with immunosuppression or specified chronic respiratory disease. The programme is year-round, but social care providers should prepare before the date so that admission checks, consent processes, delivery arrangements and records are ready.
This article concerns England. Providers in Scotland, Wales and Northern Ireland should check their own national arrangements.
What changes on 1 September 2026?
The older-adult RSV programme is expanding in England. From 1 September 2026, a single RSV vaccine dose is offered to:
- everyone aged 75 and over;
- adults residing in, or moving into, a care home for older adults; and
- people aged 65 to 74 who are immunosuppressed or have a qualifying chronic respiratory disease, as defined in the RSV Green Book chapter.
There is currently no upper age limit for the programme. It is an ongoing, year-round offer rather than an annual seasonal vaccine, and no revaccination is currently recommended.
This matters because a move into an older-adult care home can itself bring a previously unvaccinated adult aged 18 to 74 into scope. UKHSA identifies admission as an opportunity to check RSV vaccination status and offer vaccination where appropriate.
The care-home category needs local judgement
There is no single programme-wide definition of a “care home for older adults”. GP practices are expected to use clinical judgement, taking account of the home’s classification, the age mix of residents and relevant frailty or health conditions.
A provider should therefore agree a local approach with the resident’s GP practice or vaccination provider. Do not assume that a home’s name, registration description or a resident’s age alone answers every eligibility question.
Who is not eligible solely because they live in the home?
A few boundaries are worth making clear in staff briefings:
- Residents under 18 are not eligible solely because they live in an older-adult care home.
- Social-care staff who reside in the home are not eligible solely on that basis.
- A temporary resident under 75 on a planned short stay would not ordinarily be offered RSV vaccine because of that stay alone.
However, a temporary resident who is age-eligible or belongs to a qualifying clinical-risk group may be eligible through the routine programme. The responsible clinical provider should confirm this.
Why RSV planning belongs in adult social care
Previous RSV infection provides only partial immunity, so adults can get RSV again. The impact can be especially significant for older people and people with specified health risks.
The social care contribution is practical and valuable: services can spot a missed opportunity, help the person access information in a suitable format, ensure the right people are involved in decision-making and prevent vaccination records being lost during admission or transfer.
It is also an equity issue. The most recent coverage figures reported in UKHSA practitioner guidance show overall coverage of 61.9% among eligible people, but a gap between the most deprived decile (48.5%) and least deprived decile (70.1%). Clear, accessible processes can help reduce avoidable barriers to an offer being understood and acted on.
Build an RSV readiness register before September
A resident-level register gives the team a controlled way to prepare without asking care staff to make clinical decisions outside their role. It can be incorporated into an existing admissions, vaccination or health-review process.
For each resident, consider recording:
- Age and admission status — including whether the person lives in, or is moving into, an older-adult care home.
- Known RSV vaccination history — including whether an NHS RSV dose has already been given.
- Potential 65–74 clinical-risk eligibility — flag this for GP or vaccination-provider confirmation; do not diagnose or infer eligibility without appropriate clinical information.
- Consent status — and any communication support needed for the individual decision.
- Capacity pathway where relevant — including whether a decision-specific capacity assessment and best-interests process may be needed.
- Known contraindications or reasons to defer — for review by the clinical provider, such as a previous confirmed anaphylactic reaction or an acute feverish illness.
- Named responsible provider — GP practice, pharmacy or vaccination team.
- Offer, outcome and follow-up — accepted, declined, deferred, awaiting clinical confirmation or already vaccinated.
- Administration details once supplied — vaccine brand, batch number and administration site.
The purpose is continuity and safe coordination, not a parallel clinical record. Agree locally who owns the register, how it is updated and how relevant information is shared with the vaccination provider.
Make admission checks routine, not a one-off campaign
The most reliable process is usually the one embedded in everyday work. Add RSV status to the admission checklist and consider checking it again at routine reviews or when a resident’s GP information is updated.
A simple admission prompt could be:
“Has RSV vaccination status been checked, and has the responsible provider been asked to confirm whether an offer is due?”
This avoids a common problem: discovering months later that a resident was unvaccinated but no clear referral, offer or outcome was recorded.
Prevent duplicate doses
The NHS older-adult programme currently uses a single-dose schedule. A person who has already received an NHS RSV dose does not ordinarily need another dose simply because they later turn 75 or move into a different eligible group.
For that reason, confirming history and sharing administration records matters. CQC advises recording the exact vaccine brand, batch number and administration site, with clear prescribing and administration records shared appropriately to reduce the risk of duplicate doses.
Agree who does what before any clinic is booked
Vaccines are prescription-only medicines. Supply and administration need appropriate legal authority, such as a patient-specific prescription or direction (PSD), or a patient group direction (PGD). UKHSA notes that its RSV PGD requires local signed authorisation before use.
CQC says care providers should be clear about who is responsible for vaccine administration, for example the care home, a pharmacy or a GP practice. Nurses administering vaccines in care homes must have a valid PSD and be trained and competent.
A written local agreement should clarify:
- who identifies and clinically confirms eligibility;
- who reviews suitability, contraindications and deferral;
- who obtains the prescription or ensures valid PGD arrangements;
- who gives the vaccine and manages immediate adverse-event arrangements;
- who records vaccination on the relevant clinical system;
- who gives information to the resident, family or representative where appropriate; and
- who follows up where an offer is declined, deferred or missed.
Care staff can identify possible eligibility and support access. Clinical assessment, prescribing authority, vaccine suitability and administration sit with the responsible qualified provider.
Support consent and decision-making properly
Vaccination should be given only with consent. In care homes, this must be approached as a decision about this specific vaccine at this specific time.
Under the Mental Capacity Act 2005, start by presuming a person has capacity unless it is established otherwise. Take practicable steps to help them decide, and do not treat an unwise decision as proof that they lack capacity.
Useful support may include allowing time, involving a trusted person where appropriate, using plain language and requesting information in an accessible format. UKHSA provides RSV patient materials in formats including Easy Read, other languages, Braille, British Sign Language and audio.
If the person lacks capacity for this decision
Where a person lacks capacity, any decision or act must be in their best interests and use the least restrictive effective option. The Mental Capacity Act best-interests process includes considering:
- the relevant circumstances;
- how the person can participate as fully as possible;
- their past and present wishes, feelings, beliefs and values; and
- where practicable and appropriate, the views of those involved in their welfare, as well as any attorney or deputy.
Record the decision-specific process: the steps taken to support the person, relevant views and wishes, consultations undertaken, and the best-interests rationale. Check whether a health-and-welfare attorney or deputy has authority relevant to the decision.
Plan appointments around winter, without treating RSV as seasonal-only
RSV vaccination can be given throughout the year. However, protecting eligible people before the main winter RSV period has the greatest impact.
For a care-home service, that means planning early enough to resolve status checks, clinical queries and consent issues before winter demand builds. It does not mean that an eligible person should wait unnecessarily for a particular season or clinic date.
UKHSA encourages RSV and COVID-19 vaccination at the same visit where appropriate. There is no minimum interval if they are given separately. RSV and influenza vaccines should not routinely be arranged for the same appointment or day, although co-administration may be considered where immediate protection is needed or return is unlikely. These decisions should be made by the responsible clinical provider in line with current guidance and the individual’s circumstances.
Safety points staff should recognise and escalate
The vaccination provider is responsible for clinical assessment. Care staff can still help by ensuring relevant information is not missed.
UKHSA lists confirmed anaphylaxis to a previous dose or a vaccine component as a contraindication. Vaccination should be postponed when a person has an acute illness with fever, until they have recovered. A minor illness, such as a common cold, is not itself a contraindication.
Before an in-home clinic, ensure the provider has the information it needs and that emergency and access arrangements have been agreed. CQC highlights the need for trained, competent vaccinators and emergency planning appropriate to the setting.
A practical team checklist
Before 1 September 2026, an adult social care service can check that it has:
- identified its local GP, pharmacy or vaccination-provider contact;
- agreed how the home will be considered for the older-adult care-home programme;
- added RSV status to admission and review processes;
- created a resident-level readiness register;
- set a process for flagging possible 65–74 risk-group eligibility for clinical confirmation;
- agreed consent, communication-support and Mental Capacity Act documentation processes;
- clarified who will record and share vaccine brand, batch number and administration site;
- planned how missed, deferred or declined offers will be followed up; and
- briefed staff on the limits of their role and escalation routes.
Frequently asked questions
Is RSV vaccination an annual vaccine for care-home residents?
No. The NHS older-adult RSV programme in England is currently a one-dose programme. No revaccination is currently recommended.
Can a resident aged under 75 be eligible because they move into an older-adult care home?
Yes. From 1 September 2026, adults residing in or moving into a care home for older adults are eligible if previously unvaccinated. The local GP practice or vaccination provider should confirm how the home is classified for the programme.
Are all 65 to 74-year-olds eligible for RSV vaccination?
No. This age group is eligible if the person is immunosuppressed or has qualifying chronic respiratory disease as defined in UKHSA guidance. Well-controlled asthma is not an indication. Clinical confirmation should be obtained from the responsible provider.
Can staff consent on behalf of a resident?
Care staff should support the person’s decision-making and follow local processes. If the person lacks capacity for this specific decision, the Mental Capacity Act 2005 best-interests process must be followed. Relevant attorneys, deputies and people involved in the person’s welfare should be considered where practicable and appropriate.
Can RSV and flu vaccines be given at the same appointment?
They should not routinely be scheduled for the same appointment or day. UKHSA says they may be co-administered when immediate protection is needed or a return visit is unlikely. The responsible clinical provider should decide based on individual circumstances.
Conclusion: turn eligibility into a safe, documented offer
The 1 September 2026 expansion makes RSV readiness a practical adult social care issue, particularly at admission. A robust process does not require care staff to become vaccinators or make clinical decisions. It requires clear checks, respectful support for consent, dependable partnership with the vaccination provider and records that travel with the person.
The best preparation is to agree the pathway now, test it against a typical admission and make RSV status part of routine safe care.
Clarivive MedInsight encourages teams to use this change as a discussion point in admissions, medicines and vaccination governance meetings. Shared understanding of eligibility, consent and escalation helps staff support residents with confidence.
